Mary Lou Glotzbach
Senior Business Development Manager

About

Mary Lou Glotzbach, Senior Business Development Manager at Grand River Aseptic Manufacturing (GRAM), has over 20 years of CDMO industry experience in managing pharma and biopharma alliances, primarily through aseptic manufacturing and packaging programmes. As part of the GRAM team since 2020, Ms Glotzbach managed the J&J and BARDA alliances while the organisations came together to successfully manufacture the covid-19 vaccine. Her new focus is in developing and executing strategic device partnerships.

Prior to joining GRAM, Ms Glotzbach held various business development and marketing roles within the CDMO organisations at Abbott Laboratories, Hospira and Pfizer. Her experience in the healthcare market also includes the management of pharmaceutical and device sales teams while at Abbott and Hospira. Ms Glotzbach holds a BS in Biomedical
Engineering from the University of Iowa (Iowa City, IA, US). She has completed multiple executive education programmes at the Kellogg School of Management (Evanston, IL, US) and The Wharton School (Philadelphia, PA, US).

Contributions

WEARABLES

THE POWER OF PARTNERSHIP AND CLOSE COLLABORATION FOR FILLING ON-BODY INJECTORS

Mary Lou Glotzbach and Dr Greg Moakes consider the implications of the increasing demand for high-volume injections across the drug delivery industry, and how technologies such as wearable injectors are creating novel challenges for the fill-finish process due to the novel containers involved, making the case that it is only through clear communication and close collaboration between partners that these challenges can be met and surmounted.